Genetic variation predicts serum lycopene concentrations in a multiethnic population of postmenopausal women.

BACKGROUND The consumption and blood concentrations of lycopene are both positively and inversely associated with the risk of several chronic diseases. The inconsistences in lycopene disease association studies may stem from a lack of knowledge about the genetic variation in the synthesis, metabolism, and deposition of transport and binding proteins, which potentially influence serum lycopene concentrations. OBJECTIVE We examined the association between variation across the genome and serum concentrations of lycopene in a multiethnic population. METHODS Participants included African (n = 914), Hispanic (n = 464), and European (n = 1203) American postmenopausal women from the Women's Health Initiative. We analyzed ∼7 million single nucleotide polymorphisms (SNPs). Linear regression models were used to assess associations between each SNP and serum concentrations (log transformed, continuous) of lycopene; we adjusted for age, body mass index, and population substructure. Models were run separately by ethnicity, and results were combined in a transethnic fixed-effects meta-analysis. RESULTS In the meta-analysis, the scavenger receptor class B, member 1 (SCARB1) gene, which encodes for a cholesterol membrane transporter, was significantly associated with lycopene concentrations (rs1672879; P < 2.68 × 10(-9)). Each additional G allele resulted in a 12% decrease in lycopene concentrations for African Americans, 20% decrease for Hispanic Americans, and 9% decrease for European Americans. In addition, 2 regions were significantly associated with serum lycopene concentrations in African Americans: the slit homolog 3 gene (SLIT3), which serves as a molecular guidance cue in cellular migration, and the dehydrogenase/reductase (SDR family) member 2 (DHRS2) gene, which codes for an oxidoreductase that mitigates the breakdown of steroids. CONCLUSIONS We found 3 novel loci associated with serum lycopene concentrations, 2 of which were specific to African Americans. Future functional studies looking at these specific genes may provide insight into the metabolism and underlying function of lycopene in humans, which may further elucidate lycopene's influence on disease risk and health. This trial was registered at clinicaltrials.gov as NCT00000611.

[1]  P. Borel,et al.  Interindividual variability of lutein bioavailability in healthy men: characterization, genetic variants involved, and relation with fasting plasma lutein concentration. , 2014, The American journal of clinical nutrition.

[2]  M. Loda,et al.  Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. , 2014, Journal of the National Cancer Institute.

[3]  J. Erdman,et al.  Complex interactions between dietary and genetic factors impact lycopene metabolism and distribution. , 2013, Archives of biochemistry and biophysics.

[4]  E. Harrison,et al.  Substrate Specificity of Purified Recombinant Human β-Carotene 15,15′-Oxygenase (BCO1)* , 2013, The Journal of Biological Chemistry.

[5]  B. Clevidence,et al.  Strong and weak plasma response to dietary carotenoids identified by cluster analysis and linked to beta-carotene 15,15'-monooxygenase 1 single nucleotide polymorphisms. , 2013, The Journal of nutritional biochemistry.

[6]  H. Guan,et al.  Down-regulation of miR-218-2 and its host gene SLIT3 cooperate to promote invasion and progression of thyroid cancer. , 2013, The Journal of clinical endocrinology and metabolism.

[7]  Ralph Rühl,et al.  Lycopene-derived bioactive retinoic acid receptors/retinoid-X receptors-activating metabolites may be relevant for lycopene's anti-cancer potential. , 2013, Molecular nutrition & food research.

[8]  P. Calder,et al.  CD36 and SR-BI are involved in cellular uptake of provitamin A carotenoids by Caco-2 and HEK cells, and some of their genetic variants are associated with plasma concentrations of these micronutrients in humans. , 2013, The Journal of nutrition.

[9]  J. Buring,et al.  Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies. , 2012, Journal of the National Cancer Institute.

[10]  Sergio Tofanelli,et al.  Molecular and functional evolution of human DHRS2 and DHRS4 duplicated genes. , 2012, Gene.

[11]  W. Willett,et al.  β-Carotene 15,15'-monooxygenase 1 single nucleotide polymorphisms in relation to plasma carotenoid and retinol concentrations in women of European descent. , 2012, The American journal of clinical nutrition.

[12]  Xiang‐Dong Wang.  Lycopene metabolism and its biological significance. , 2012, The American journal of clinical nutrition.

[13]  L. Wood,et al.  Tomato juice consumption reduces systemic inflammation in overweight and obese females , 2012, British Journal of Nutrition.

[14]  P. Palozza,et al.  Effect of Lycopene and Tomato Products on Cholesterol Metabolism , 2012, Annals of Nutrition and Metabolism.

[15]  D. Greenwood,et al.  Dietary compared with blood concentrations of carotenoids and breast cancer risk: a systematic review and meta-analysis of prospective studies. , 2012, The American journal of clinical nutrition.

[16]  J. Marchini,et al.  Fast and accurate genotype imputation in genome-wide association studies through pre-phasing , 2012, Nature Genetics.

[17]  B. Henderson,et al.  Prediagnostic circulating carotenoid levels and the risk of non-Hodgkin lymphoma: the Multiethnic Cohort. , 2012, Blood.

[18]  R. Wolff,et al.  Oxidative balance and colon and rectal cancer: interaction of lifestyle factors and genes. , 2012, Mutation research.

[19]  J. Shikany,et al.  Repeated measurements of serum carotenoid, retinol and tocopherol levels in relation to colorectal cancer risk in the Women's Health Initiative , 2012, European Journal of Clinical Nutrition.

[20]  W. Simpson,et al.  Effect of a tomato-rich diet on markers of cardiovascular disease risk in moderately overweight, disease-free, middle-aged adults: a randomized controlled trial. , 2012, The American journal of clinical nutrition.

[21]  J. Erdman,et al.  Are lycopene metabolites metabolically active? , 2012, Acta biochimica Polonica.

[22]  L. Barraj,et al.  Phytonutrient intake by adults in the United States in relation to fruit and vegetable consumption. , 2012, Journal of the Academy of Nutrition and Dietetics.

[23]  A. Bosserhoff,et al.  Slit3 inhibits activator protein 1-mediated migration of malignant melanoma cells. , 2011, International journal of molecular medicine.

[24]  P. Palozza,et al.  Lycopene regulation of cholesterol synthesis and efflux in human macrophages. , 2011, The Journal of nutritional biochemistry.

[25]  Eleazar Eskin,et al.  Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. , 2011, American journal of human genetics.

[26]  L. Arab,et al.  Racial differences in correlations between reported dietary intakes of carotenoids and their concentration biomarkers. , 2011, The American journal of clinical nutrition.

[27]  C. Dufour,et al.  Vitamin D intestinal absorption is not a simple passive diffusion: evidences for involvement of cholesterol transporters. , 2011, Molecular nutrition & food research.

[28]  L. Ferrucci,et al.  Low-serum carotenoid concentrations and carotenoid interactions predict mortality in US adults: the Third National Health and Nutrition Examination Survey. , 2011, Nutrition research.

[29]  I. Thompson,et al.  Serum Lycopene Concentration and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[30]  Jan Albert Kuivenhoven,et al.  Genetic variant of the scavenger receptor BI in humans. , 2011, The New England journal of medicine.

[31]  Belinda E. Clarke,et al.  MicroRNA-218 Is Deleted and Downregulated in Lung Squamous Cell Carcinoma , 2010, PloS one.

[32]  D. Oh,et al.  Substrate specificity of a recombinant chicken β-carotene 15,15′-monooxygenase that converts β-carotene into retinal , 2009, Biotechnology Letters.

[33]  Luigi Ferrucci,et al.  Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study. , 2009, American journal of human genetics.

[34]  B. Browning,et al.  A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. , 2009, American journal of human genetics.

[35]  E. Reboul,et al.  Lycopene absorption in human intestinal cells and in mice involves scavenger receptor class B type I but not Niemann-Pick C1-like 1. , 2008, The Journal of nutrition.

[36]  Nilanjan Chatterjee,et al.  Serum Lycopene, Other Carotenoids, and Prostate Cancer Risk: a Nested Case-Control Study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial , 2007, Cancer Epidemiology Biomarkers & Prevention.

[37]  D. Reich,et al.  Population Structure and Eigenanalysis , 2006, PLoS genetics.

[38]  L. Lagrost,et al.  Scavenger Receptor Class B Type I (SR-BI) Is Involved in Vitamin E Transport across the Enterocyte* , 2006, Journal of Biological Chemistry.

[39]  J. Erdman.  How do nutritional and hormonal status modify the bioavailability, uptake, and distribution of different isomers of lycopene? , 2005, The Journal of nutrition.

[40]  N. Risch,et al.  Estimation of individual admixture: Analytical and study design considerations , 2005, Genetic epidemiology.

[41]  J. Ordovás,et al.  A polymorphism exon 1 variant at the locus of the scavenger receptor class B type I (SCARB1) gene is associated with differences in insulin sensitivity in healthy people during the consumption of an olive oil-rich diet. , 2005, The Journal of clinical endocrinology and metabolism.

[42]  H. Hauser,et al.  Class B scavenger receptor-mediated intestinal absorption of dietary beta-carotene and cholesterol. , 2005, Biochemistry.

[43]  I. Bièche,et al.  Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers , 2004, British Journal of Cancer.

[44]  Scott Davis,et al.  Implementation of the Women's Health Initiative study design. , 2003, Annals of epidemiology.

[45]  S. Andersson,et al.  Biochemical Properties of Purified Recombinant Human β-Carotene 15,15′-Monooxygenase* , 2002, The Journal of Biological Chemistry.

[46]  J. Erdman,et al.  Factors that influence the bioavailablity of xanthophylls. , 2002, The Journal of nutrition.

[47]  S. Squazzo,et al.  Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[48]  Fan Wang,et al.  Carotenoids and breast cancer risk: a meta-analysis and meta-regression , 2011, Breast Cancer Research and Treatment.

[49]  L. Kaplan,et al.  Simultaneous measurement of serum retinol, tocopherols, carotenes, and carotenoids by high performance liquid chromatography , 1987 .